Aberdeen Group
INSM icon

Aberdeen Group’s Insmed INSM Stock Holding History

Aberdeen Group’s Portfolio INSM Stock Details INSM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$61.6M Buy
577,437
+300,421
+108% +$36.4M 0.09% 190
2026
Q1 		$45.3M Buy
277,016
+23,904
+9% +$3.68M 0.07% 230
2025
Q4 		$44.1M Buy
253,112
+18,490
+8% +$3.37M 0.07% 237
2025
Q3 		$33.8M Sell
234,622
-75,127
-24% -$9.2M 0.05% 294
2025
Q2 		$31.2M Sell
309,749
-26,608
-8% -$2.03M 0.05% 303
2025
Q1 		$25.7M Buy
336,357
+46,704
+16% +$3.57M 0.05% 327
2024
Q4 		$20M Buy
289,653
+178,041
+160% +$12.8M 0.04% 369
2024
Q3 		$8.15M Hold
111,612
– – 0.01% 558
2024
Q2 		$7.48M Sell
111,612
-21,887
-16% -$849K 0.01% 562
2024
Q1 		$3.62M Buy
133,499
+33,499
+33% +$938K 0.01% 712
2023
Q4 		$3.1M Buy
+100,000
New +$2.59M 0.01% 738

Other funds holding INSM

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
DGM
Darwin Global Management St. Helier, Jersey $3.76B AUM 342.13% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $495B AUM 43.24% 1-Year Est. Return
OAG
Orbis Allan Gray Hamilton, Bermuda $29.1B AUM 60.8% 1-Year Est. Return

Aberdeen Group's INSM Position: Q2 2026 in Review

Aberdeen Group increased its Insmed (INSM) stake by 108% in Q2 2026, buying an estimated $36.4M and bringing the position to 577,437 shares worth $61.6M. The position accounts for 0.09% of the portfolio, ranked #190.

Aberdeen Group first reported a position in INSM in Q4 2023 and has held it in 11 quarters since. 666 funds tracked by Wall St. Rank hold INSM as of Q2 2026.

  • Aberdeen Group held 577,437 shares of Insmed worth $61.6M as of Q2 2026.
  • Aberdeen Group bought 300,421 Insmed shares in Q2 2026, an estimated $36.4M.
  • Insmed made up 0.09% of Aberdeen Group's portfolio in Q2 2026, its #190 holding.
  • Aberdeen Group first reported a position in Insmed in Q4 2023 and has held it in 11 quarters since.
  • 666 funds tracked by Wall St. Rank held Insmed as of Q2 2026.

Based on Aberdeen Group's 13F filing for Q2 2026, filed 31 Jul 2026.